Yield10 Bioscience, Inc. Common Stock
YTEN
YTEN was delisted on the 15th of May, 2024.
14 hedge funds and large institutions have $9.75M invested in Yield10 Bioscience, Inc. Common Stock in 2014 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
8% more funds holding
Funds holding: 13 → 14 (+1)
5% more capital invested
Capital invested by funds: $9.28M → $9.75M (+$474K)
0% more call options, than puts
Call options by funds: $1K | Put options by funds: $1K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$158K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$158K |
| 3 |
AG
Aperio Group
Sausalito,
California
|
+$79.2K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$79.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VKH
Virtu KCG Holdings
New York
|
-$158K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
U
26
UBS
Zurich,
Switzerland
| $5K | – | – | – |
|
27
Creative Planning
Overland Park,
Kansas
| $3K | – | – | – |
|
28
Citigroup
New York
| $2K | – | – | – |
|
29
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $1K | – | – | – |
|
|
MCM
30
Manchester Capital Management
Manchester,
Vermont
| $1K | – | – | – |
|
31
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $1K | – | – | – |
|
|
PSC
32
Prentiss Smith & Co
Brattleboro,
Vermont
| $1K | – | – | – |
|
33
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | – | – | – |
|
34
Wells Fargo
San Francisco,
California
| $1K | – | – | – |
|
35
BNP Paribas Financial Markets
Paris,
France
| $557 | – | – | – |
|
|
WEC
36
Winslow Evans & Crocker
Boston,
Massachusetts
| $260 | – | – | – |
|
37
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $1 | – | – | – |
|
|
TRCT
38
Tower Research Capital (TRC)
New York
| – | -$3K | – | – |
|
YTEN Hedge Fund Activity: Q1 2014 in Review
14 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in Yield10 Bioscience, Inc. Common Stock (YTEN) for Q1 2014, worth a combined $9.75M — up 5.1% from $9.28M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new YTEN positions and 1 closed out — a net gain of 1 holder — while 2 added to existing stakes and 0 trimmed.
The largest buyer was BlackRock Institutional Trust, adding an estimated $158K. The largest seller was Virtu KCG Holdings, exiting entirely with an estimated $158K sold.
- 14 institutional investors held Yield10 Bioscience, Inc. Common Stock (YTEN) as of Q1 2014, up from 13 in Q4 2013.
- Funds reported $9.75M of Yield10 Bioscience, Inc. Common Stock stock for Q1 2014, up 5.1% quarter-over-quarter.
- 2 funds opened new Yield10 Bioscience, Inc. Common Stock positions in Q1 2014 and 1 closed out, a net change of +1 holder.
- The largest Yield10 Bioscience, Inc. Common Stock buyer in Q1 2014 was BlackRock Institutional Trust, an estimated $158K added.
- The largest Yield10 Bioscience, Inc. Common Stock seller in Q1 2014 was Virtu KCG Holdings, an estimated $158K sold.
Based on aggregated 13F filings for Q1 2014.